Tag: opioid addiction treatment
-
Indivior to Delist from LSE, Focus on US Market
Indivior, a global pharmaceutical firm specializing in opioid addiction treatment, has decided to delist from the London Stock Exchange (LSE) and focus solely…
-
Indivior’s Exit Adds Pressure on London Stock Exchange
London Stock Exchange has witnessed a growing trend of companies abandoning their listings, with drugmaker Indivior being the latest to join this exodus.…
-
Indivior to Delist from London Stock Exchange, Focus on Nasdaq
Pharmaceutical company Indivior has decided to delist from the London Stock Exchange, effective July 25, while maintaining its primary listing on the Nasdaq.…
-
Indivior Shifts Primary Listing to Nasdaq for Strategic Growth
Indivior, a pharmaceutical company renowned for its opioid addiction treatments, has announced its decision to delist from the London Stock Exchange (LSE) effective…